Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder—clinical and histopathologic features, differential diagnosis, and treatment
Seminars in Cutaneous Medicine and Surgery · 2018-03 · 37 (1) · 39-48
DOI: 10.12788/j.sder.2018.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cutaneous Medicine and Surgery, 2018-03. Verfasst von Alejandro A Gru und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Dermatology, Division of Dermatopathology, University of Virginia, Charlottesville, Virginia, USA. AAG4B@hscmail.mcc.virgin…. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 37-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pathology & Dermatology, Division of Dermatopathology, University of Virginia, Charlottesville, Virginia, USA. AAG4B@hscmail.mcc.virginia.edu.
- Department of Pathology & Dermatology, Division of Dermatopathology, University of Virginia, Charlottesville, Virginia, USA.
Zitieren
APA
Gru, A. A., Wick, M. R., & Eid, M. (2018). Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder—clinical and histopathologic features, differential diagnosis, and treatment. Seminars in Cutaneous Medicine and Surgery, 37(1), 39-48. https://doi.org/10.12788/j.sder.2018.006
Vancouver
Gru AA, Wick MR, Eid M. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder—clinical and histopathologic features, differential diagnosis, and treatment. Seminars in Cutaneous Medicine and Surgery. 2018;37(1):39-48. doi:10.12788/j.sder.2018.006
BibTeX
@article{Gru2018,
author = {Gru, Alejandro A and Wick, Mark R and Eid, Mary},
title = {Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder—clinical and histopathologic features, differential diagnosis, and treatment},
journal = {Seminars in Cutaneous Medicine and Surgery},
year = {2018},
volume = {37},
number = {1},
pages = {39--48},
doi = {10.12788/j.sder.2018.006}
}
EUVIMED